Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients

BACKGROUND: After successful of antiretroviral therapy, highly effective direct acting antiviral (DAA) make HCV elimination reasonable in HIV/HCV co-infected patients. However, in achieving this target, there are still barriers to start DAA treatment, particularly in the area of liver fibrosis asses...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Infect Dis
Auteurs principaux: Yunihastuti, Evy, Wicaksana, Bramantya, Wiraguna, Andrian, Hidayah, Ainum Jhariah, Amelia, Fhadilla, Natali, Veritea, Widhani, Alvina, Sulaiman, Andri Sanityoso, Kurniawan, Juferdy
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7249442/
https://ncbi.nlm.nih.gov/pubmed/32450844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05069-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires